Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
58,400
+700 (1.21%)
Sep 17, 2025, 3:30 PM KST
Mezzion Pharma Revenue
Mezzion Pharma had revenue of 1.74B KRW in the quarter ending June 30, 2025, a decrease of -23.12%. This brings the company's revenue in the last twelve months to 7.88B, down -61.07% year-over-year. In the year 2024, Mezzion Pharma had annual revenue of 8.61B, down -72.85%.
Revenue (ttm)
7.88B
Revenue Growth
-61.07%
P/S Ratio
223.11
Revenue / Employee
437.92M
Employees
18
Market Cap
1,758.71B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 8.61B | -23.11B | -72.85% |
Dec 31, 2023 | 31.72B | 994.76M | 3.24% |
Dec 31, 2022 | 30.73B | 4.07B | 15.28% |
Dec 31, 2021 | 26.65B | -1.98B | -6.92% |
Dec 31, 2020 | 28.63B | 10.71B | 59.79% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.16T |
Samsung Biologics | 5,031.69B |
Hanwha Aerospace | 19.25T |
Hyundai Motor Company | 182.25T |
HD Hyundai Heavy Industries | 15.58T |
KB Financial Group | 14.92T |